首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   14820篇
  免费   996篇
  国内免费   498篇
耳鼻咽喉   215篇
儿科学   453篇
妇产科学   213篇
基础医学   1662篇
口腔科学   296篇
临床医学   1517篇
内科学   3020篇
皮肤病学   288篇
神经病学   920篇
特种医学   488篇
外国民族医学   2篇
外科学   1444篇
综合类   1384篇
一般理论   2篇
预防医学   1263篇
眼科学   491篇
药学   1169篇
  7篇
中国医学   451篇
肿瘤学   1029篇
  2024年   24篇
  2023年   130篇
  2022年   264篇
  2021年   469篇
  2020年   319篇
  2019年   380篇
  2018年   550篇
  2017年   395篇
  2016年   381篇
  2015年   520篇
  2014年   627篇
  2013年   734篇
  2012年   1098篇
  2011年   1214篇
  2010年   735篇
  2009年   532篇
  2008年   831篇
  2007年   859篇
  2006年   743篇
  2005年   784篇
  2004年   658篇
  2003年   623篇
  2002年   570篇
  2001年   479篇
  2000年   504篇
  1999年   388篇
  1998年   116篇
  1997年   101篇
  1996年   101篇
  1995年   91篇
  1994年   54篇
  1993年   51篇
  1992年   143篇
  1991年   118篇
  1990年   102篇
  1989年   107篇
  1988年   88篇
  1987年   75篇
  1986年   66篇
  1985年   50篇
  1984年   38篇
  1983年   23篇
  1982年   13篇
  1981年   9篇
  1980年   11篇
  1979年   14篇
  1977年   12篇
  1973年   9篇
  1970年   9篇
  1965年   8篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
141.
Percutaneous vertebroplasty: a special syringe for cement injection   总被引:6,自引:0,他引:6  
Percutaneous vertebroplasty is an effective treatment for many focal vertebral lesions. Methyl methacrylate is too viscous to be handled without difficulty in the conventional way because injection time is short. The operator is left with little time and must fumble with multiple syringes. We describe a special screw-system syringe that decreases the effort needed to inject the cement. In addition, it can standardize the injection pressures and control the injected volume because the threaded plunger affords greater control of injection pressure and volume delivered than does the conventional method.  相似文献   
142.
Current treatment of chronic anal fissure continues to be based on conventional conservative measures in a high percentage of cases. What is known as chemical sphincterotomy aims to achieve a temporary decrease of anal pressures that allows fissures to heal. There are various alternatives such as nitroglycerine or diltiazem ointment and botulinum toxin injections. However, because of collateral effects and recurrences in the medium term, the definitive role of these treatments remains to be elucidated. Nevertheless, chemical sphincterotomy should be the first option in patients with a high risk of incontinence. "Open" or "closed" lateral internal sphincterotomy performed in the ambulatory setting with local anesthesia can currently be considered the ideal treatment of chronic anal fissure refractory to conservative measures so long as the patient is informed about the risk of minor incontinence. This procedure provides rapid and permanent recovery in more than 95% of patients. There is evidence demonstrating that the incontinence rate is related to the extent of the lateral internal sphincterotomy and consequently the extent of this procedure should be reduced to the length of the fissure.  相似文献   
143.
CD80 is expressed on all antigen-presenting cells and is present on podocytes in a number of experimental models of nephrotic syndrome. We tested whether urinary soluble CD80 increased with idiopathic minimal-change disease (MCD). We collected urine and serum samples from patients with MCD in relapse and in remission, patients with nephrotic syndrome resulting from other glomerular diseases (FSGS, membranoproliferative glomerulonephritis, IgA nephropathy, and membranous nephropathy), patients with systemic lupus erythematosus, and normal control subjects. Urinary concentrations of soluble CD80 in patients with relapsed MCD were significantly higher compared with those observed in patients with MCD in remission, other glomerular diseases, and systemic lupus erythematosus with and without proteinuria and healthy control subjects. Urinary concentrations of soluble CTLA-4, which is a negative regulator of CD80, were not statistically different in patients with relapsed MCD compared with those in remission. The urinary soluble CD80/CTLA-4 ratio was >100-fold higher in patients with relapsed MCD compared with those in remission (P < 0.008). In contrast, serum concentrations of soluble CD80 and CTLA-4 did not distinguish patients with MCD in relapse and in remission. In conclusion, urinary soluble CD80 is elevated in idiopathic MCD, which could be relevant to both diagnosis and pathogenesis.Idiopathic minimal-change disease (MCD) is the most common nephrotic syndrome in children and adolescents.1 The disease is considered a disorder of T cell function.2,3 Although the mechanism of the proteinuria is unknown, a circulating cytokine has been postulated as the link between proteinuria and the T cell dysfunction.24Podocytes are specialized and highly differentiated epithelial cells that form a layer between the glomerular basement membrane and the urinary space. In a series of experiments, Reiser et al.5 found that these cells could acquire dendritic cell–like functions, in which they can be induced to express CD80, a transmembrane protein that provides a co-stimulatory signal for T cell activation. Mice administered LPS developed podocyte CD80 expression and proteinuria; when LPS was administered to the CD80−/− knockout mouse, no increase in urinary protein excretion was observed.5 The authors further showed that podocyte CD80 activation by LPS could occur in SCID mice that lack T cells.5 Furthermore, CD80 expression could be shown in both experimental models of nephrotic syndrome (e.g., aminonucleoside nephrosis) and human lupus nephritis.5 These findings led the authors to propose that podocyte CD80 expression might be involved in the pathogenesis of MCD.6Some podocyte antigens are known to be shed, where they can be found in the urine.7 This led us to hypothesize that soluble CD80 (sCD80) might be detected in the urine in patients with MCD. Furthermore, T regulatory cells are known to secrete soluble CTLA-4 (sCTLA-4), which can bind CD80 and block the co-stimulatory activation of T cells.810 If T cells are releasing a cytokine that can induce MCD, such as IL-13,11 then one might postulate that an inadequate release of sCTLA-4 might lead to continued activation of the T cells and possibly persistent CD80 expression by dendritic cells. We therefore measured urinary sCD80 and urinary sCTLA-4 levels in children with MCD and compared the findings with healthy children and children with other glomerular diseases.Clinical characteristics of the patients with MCD and control groups are shown in
PatientAge (yr)GenderDiagnosisUrinary sCD80 (ng/g creatinine)Serum Albumin (g/dl)Up/Uc RatioTreatment
MCD in relapse
    118F21143.91.1Prednisone 60 mg/d
    24M1762.716.7None
    33M472N/A10.2Prednisone 33 mg/d
    42F1563.23.8None
    51M473N/A13.1Prednisone 18 mg every other day
    613M50335.2Prednisone 5 mg every other day
    78F9362.27.9Prednisone 15 mg/d
    86M46025.3None
    93M4642.440.8None
    104F1612.71.3None
    113M3091.76.04Prednisone 30 mg/d
    1216F216N/A14.5Prednisone 10 mg every other day
    135M21031.317.6Prednisone 30 mg/d
    142F8492.74.2Prednisone 15 mg twice a day
    152M9191.610.2Prednisone 30 mg/d
    mean ± SEM6 ± 1687 ± 1632.5 ± 0.210.5 ± 2.6
MCD in remission
    33M110N/ANegPrednisone 30 mg/d
    42F433.2<0.61None
    53M12N/A0.32Prednisone 30 mg/d, cyclosporine 30 mg twice a day
    613M51N/A0.08Prednisone 60 mg/d
    78F133.4<0.33Prednisone 42 mg/d
    93M7N/A0.2Prednisone 30 mg/d
    104F14N/ANegPrednisone 9 mg every other day
    113M69N/A0.17Prednisone 30 mg/d
    162M113.3<0.47Prednisone 30 mg/d, cyclosporine 30 mg twice a day
    173F9440.16Prednisone 7 mg every other day, MMF 200 mg twice a day, Prograf 1.5 mg twice a day
    188F51N/A<0.23None
    1910M233.6<0.48Prednisone 60 mg/d, cyclosporine 25 mg morning and 100 mg afternoon
    mean ± SEM5 ± 141 ± 103.5 ± 0.10.25 ± 0.07
Other glomerular diseases
    2012MFSGS181.914.9None
    2117FFSGSUndetected3.42.05None
    2213MFSGSUndetected3.91.64None
    2313MFSGS224.11.12None
    2413FMPGN783.38.55Prednisone 60 mg every other day
    2413FMPGN483.24.8Prednisone 60 mg every other day
    2510FMembranous nephropathy15411.5Prednisone 40 mg every other day, Cytoxan 50 mg/d
    2616FMembranous nephropathy422.32.27Prednisone 20 mg every other day, cyclosporine 125 mg twice a day
    2711FMembranous nephropathy1583.36.8None
    2822FIgA nephropathy1441.2None
    296FIgA nephropathy790.57None
    mean ± SEM13 ± 155 ± 173.3 ± 0.35.03 ± 1.45
Control subjects
    3015M137<0.06N/A
    3118F50.19N/A
    3216M20.06N/A
    334 moM28NegN/A
    3420F15NegN/A
    353F8NegN/A
    361F152NegN/A
    375F13NegN/A
    389 moF164NegN/A
    mean ± SEM8 ± 258 ± 230.03 ± 0.02
Patients with SLE
    3940FNeg prot162Prednisone 5 mg/d, Cellcept 1.5 g/d
    4059F0.0970N/A
    4110F0.16255Prednisone 20 mg/d, Cellcept 750 mg twice a day
    4225F0.16124Imuran 150 mg/d
    4325F0.17111None
    4437F0.18122Prednisone 10 mg/d
    4546F0.2237Cellcept 1 g twice a day
    4650M0.2410Prednisone 60 mg/d
    4743F0.297N/A
    4844F0.3165Prednisone 15 mg/d
    4932F0.35444None
    5048F<0.40Prednisone 2.5 mg every other day, methotrexate 17.5 mg/wk
    5128F0.4738Prednisone 30 mg/d, Imuran 150 mg/d
    529M0.53159Methylprednisolone 1 g intravenously
    5341F0.88577N/A
    5429F0.9637Cellcept 1 g twice a day
    5520F1.2555Cellcept 1.5 g twice a day
    5644F1.335N/A
    5736M3.3280Cellcept 1.5 g twice a day
    5817F8.35122Prednisone 10 mg/d, Cellcept 750 mg twice a day
    5917F8.3524Prednisone 30 mg/d, Cellcept 1.5 g twice a day
    mean ± SEM33 ± 31.34 ± 0.53127 ± 31
Open in a separate windowaMMF, mycophenolate mofetil; MPG, membranoproliferative glomerulonephritis; Up, urine protein; Uc, urine creatinine.  相似文献   
144.
彩色多普勒对亚临床型精索静脉曲张不育患者的诊断价值   总被引:6,自引:0,他引:6  
徐卫东  刘牧  栾智勇  邓凯莉  张耀文 《中华男科学杂志》2005,11(11):815-817
目的:探讨彩色多普勒(CDFI)对亚临床型精索静脉曲张(SVC)不育患者的诊断价值。方法:采用CDFI检测56例精液异常不育患者的精索静脉,观察蔓状静脉血管内径及血液返流时间,并行X线选择性精索内静脉造影对照分析。结果:平静状态下蔓状静脉内径为(2.24±0.16)mm;Valsalva运动时内径为(2.67±0.26)mm;返流时间为(1 487±203.66)m s,CDFI检测SVC的准确性为92.8%。结论:在男性不育的病因筛选中,CDFI检测对SVC的诊断比临床型精索静脉曲张更有意义。  相似文献   
145.
肝尾状叶原发性肝细胞肝癌的外科治疗   总被引:7,自引:4,他引:7  
Peng SY  Feng XD  Liu YB  Qian HR  Li JT  Wang JW  Xu B  Fang HQ  Cao LP  Shen HW  Du JJ  Cai XJ  Mu YP 《中华外科杂志》2005,43(1):49-52
目的 探讨尾状叶原发性肝癌手术切除的方式及其影响。方法 自1995年至2003年,对39例尾状叶原发性肝癌进行了手术切除,其中单独尾状叶切除19例,联合切除20例。并对两组病例中可能影响术后肝功能的指标进行了比较。结果 39例患者均被成功切除肿瘤,1例于术后30d因肾功能衰竭死亡,3例并发胸腔积液,4例并发腹水,1例并发胆漏,其余病例均顺利恢复。术后30例获得随访,1年、3年、5年生存率分别为53%、50%、39%。结论 尾状叶切除是治疗原发于尾状叶肝癌的有效手段,若肿瘤原发于肝尾状叶而又无其他肝叶侵犯时,单独尾状叶切除该是外科治疗的最佳选择。  相似文献   
146.
11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients     
Muñoz R  Carvajal C  Escalona A  Boza C  Pérez G  Ibáñez L  Fardella C 《Obesity surgery》2009,19(6):764-770
  相似文献   
147.
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT     
Ana María García Vicente  Ángel Soriano Castrejón  Alberto León Martín  Ignacio Chacón López-Muñiz  Vicente Muñoz Madero  María del Mar Muñoz Sánchez  Azahara Palomar Muñoz  Ruth Espinosa Aunión  Ana González Ageitos 《European journal of nuclear medicine and molecular imaging》2013,40(9):1304-1311

Purpose

To determine whether the metabolic features of breast tumours differ among molecular subtypes.

Methods

This prospective study included 168 women diagnosed with locally advanced breast cancer. PET/CT was requested in the initial staging before neoadjuvant treatment (multicentre study, FISCAM grant). All patients underwent an 18F-FDG PET/CT scan with a dual time-point acquisition. Both examinations (PET-1 and PET-2) were evaluated qualitatively and semiquantitatively with calculation of SUVmax (SUV-1 and SUV-2, respectively), and the percentage variation in the SUVs and retention indexes (RI) between PET-1 and PET-2 in the breast tumour were calculated. Biological prognostic parameters, including the steroid receptor status, HER-2 expression, proliferation rate (Ki-67) and grading, were determined from primary tumour tissue. Tumour subtypes were classified following the recommendations of the 12th International Breast Conference, by immunohistochemical surrogates as luminal A, luminal B-HER2(?), luminal B-HER2(+), HER2(+) or basal. Metabolic semiquantitative parameters and molecular subtypes were correlated.

Results

Of the 168 tumours, 151 were classified: 16 were luminal A, 53 were luminal B-HER2(?), 29 were luminal B-HER2(+), 18 were HER2(+) and 35 were basal. There were significant differences between SUV-1 and SUV-2 and the different subtypes, with higher SUVs in HER2(+) and basal tumours. No significant differences were found with respect to RI.

Conclusion

Semiquantitative metabolic parameters showed statistically significant differences among the molecular subtypes of the tumours evaluated. Therefore, there seems to be a relationship between molecular and glycolytic phenotypes.  相似文献   
148.
雌二醇对去势前列腺癌患者LH脉冲分泌的抑制作用     
母义明  李江源 《解放军医学杂志》1993,18(5):346-348
3例前列腺癌施行双侧睾丸节除术后2-12周的患,每天肌注苯甲酸雌二醇1mg,d。治疗前后分别每10min采血一次,作7h LH脉冲分析。结果表明,3例患平均血清LH水平分别由177.58±3.20,138.30±5.83和145.88±3.82IU/LGHBTGC 174.90±7.60,132.02±5.77和142.80±3.65IU/L(P均<0.01),但LH脉冲幅度和频率无明显变化(  相似文献   
149.
Performance of quantitative ultrasound in the discrimination of prevalent osteoporotic fractures in a bone metabolic unit   总被引:4,自引:0,他引:4  
López-Rodríguez F  Mezquita-Raya P  de Dios Luna J  Escobar-Jiménez F  Muñoz-Torres M 《BONE》2003,32(5):571-578
There is a growing interest in ultrasound evaluation of bone status as an alternative to the measurement with dual X-ray absorptiometry (DXA), due to its low cost, portability, and nonionizing radiation. The aim of our study was to investigate the relation among DXA, QUS, clinical, anthropometric, and lifestyle factors, and to determine QUS cutoff values in order to discriminate fractures in patients referred to the Bone Metabolic Unit at an Endocrinology Service. We studied 300 patients (281 females and 19 males; age 58 +/- 11 years) referred for evaluation of osteoporosis. In all cases we determined basic anthropometric parameters, a clinical history including previous osteoporotic fractures and risk factors for osteoporosis, and QUS parameters in calcaneus (Hologic Sahara), and BMD in lumbar spine (LS) and femoral neck (FN), by DXA (Hologic QDR 1000). Using the WHO densitometric criteria, 37, 46.7, and 16.3% of our population were osteoporotic, osteopenic, and normal, respectively. A QUI T-score 相似文献   
150.
Klippel-Trenaunay综合征血管内硬化治疗的临床探讨     
吕朋华  王立富  王书祥  孙陵  耿素萍  陈明  黄文诺 《介入放射学杂志》2008,17(12):881-884
目的探讨Klippel-Trenaunay(KT)综合征血管内硬化治疗的疗效及安全性。方法6例KT综合征患者行顺行静脉造影、多普勒超声后行患肢动脉造影,并经动脉主干注入碘油平阳霉素乳剂,随访观察疗效及术后并发症。结果顺行静脉造影和多普勒超声显示单纯异常扩张浅静脉6例,深静脉无异常;动脉造影显示动脉二、三级分支增多,软组织内见染色影。术后并发症主要有肢体肿胀和感觉异常。随访8~40个月,5例肢体症状明显好转,1例症状反复。结论碘油平阳霉素乳剂血管内硬化治疗KT综合征能有效改善患肢症状。  相似文献   
[首页] « 上一页 [10] [11] [12] [13] [14] 15 [16] [17] [18] [19] [20] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号